Share

Networks

Clinical Studies (2)

  • BronchSTART : Study aims to monitor RSV disease in children under two years of age attending emergency departments across the UK and Ireland and to assess the impact of the COVID-19 pandemic on the timing, age distribution, and severity of clinical presentations
  • Moderna mRNA-1769-P101 : Study aims to assess the safety, tolerability and immunogenicity of mRNA-1769 in healthy adult participants

Study Data

  • Adults (18-64 years)
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Hospital
  • Emergency department
  • Monkeypox virus
  • Respiratory syncytial virus
  • Mpox
  • Respiratory syncytial virus infection
  • Pharmacological intervention
  • Vaccination
  • mRNA-1769

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to